MY LEO PHARMA
LIVE

Serial Number

79318552

Owner

LEO PHARMA A/S

Attorney

B. Brett Heavner

Filing Date

Jun 29, 2021

Add to watchlist:

No watchlists yet
View on USPTO

MY LEO PHARMA Trademark

Serial Number: 79318552 • Registration: 6874598

MY LEO PHARMA is a trademark filed by LEO PHARMA A/S on June 29, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

LEO PHARMA A/S (123 trademarks)

IDUSTRIPARKEN 55
BALLERUP DK-2750 , DK

Entity Type: 03

Trademark Details

Filing Date

June 29, 2021

Registration Date

October 18, 2022

Published for Opposition

August 2, 2022

Goods & Services

Providing online forums for information and communication about skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin

Pharmaceutical preparations for the treatment of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and for treatment of the skin

Medical services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical, health and pharmaceutical consultation services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical tests, namely, medical testing for diagnostic or treatment purposes in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin

Scientific and medical research in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; research in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; pharmaceutical research and development services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; scientific research for medical purposes in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; providing information and consulting services in the field of medical research, product development and scientific research in relation to skin diseases and treatment of the skin; pharmaceutical tests, namely, testing of pharmaceuticals in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Mar 7, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 6, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 10, 2023 FICS
FINAL DISPOSITION PROCESSED
Feb 10, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 18, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 18, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 18, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 2, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 2, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Aug 1, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 13, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 13, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 13, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 24, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 18, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 17, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 17, 2022 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 16, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 16, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 16, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 16, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 16, 2022 COAR
REFUSAL PROCESSED BY IB
May 24, 2022 RFNT
NEW REPRESENTATIVE AT IB RECEIVED
May 21, 2022 NREP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 5, 2022 RFCS
REFUSAL PROCESSED BY MPU
May 5, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 26, 2022 RFCR
NON-FINAL ACTION WRITTEN
Mar 25, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 21, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 31, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 27, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 26, 2021 REPR